CLDN6 and cancer: Considering the higher specificity of the novel anti-human CLDN6 mAb and the above-mentioned finding that CLDN6 is barely expressed in normal adult cells, the established mAbs could provide powerful tools that selectively recognize CLDN6 protein in a range of cancer tissues.